NCT02287376View on ClinicalTrials.gov

Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Migraine

Interventions

DRUG

Diclofenac Potassium for Oral Solution

NSAID

Trial Locations (2)

Unknown

Tampa

Amherst

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Depomed

INDUSTRY

NCT02287376 - Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds | Biotech Hunter | Biotech Hunter